Katarzyna Bachanek‐Bankowska

Author

The Pirbright Institute

Also Known As

Bachanek-Bankowska, Katarzyna, Katarzyna Bachanek-Bankowska, Katarzyna Bachanek‐Bankowska

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The Pirbright Institute Sokoine University of Agriculture Ministry of Agriculture and Rural Development Ministry of Livestock and Fisheries All-Russian Research Institute for Animal Health

About

Katarzyna Bachanek‐Bankowska is an author at The Pirbright Institute specializing in medicine, virology, and pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	585
2	Epidemiology	4	4	218
3	Immunology	4	4	156
4	Public Health	1	1	101
5	Global Health	1	1	101

Katarzyna Bachanek‐Bankowska

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Complete Genome Characterisation of a Novel 26th Bluetongue Virus Serotype from Kuwait Sushila Maan, Narender S. Maan, Kyriaki Nomikou, PLoS ONE Bluetongue VirusViral EvolutionNovel 26ThGeneticsPathogenesis	2011	177
Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus Eeva Tuppurainen, Caroline R. Pearson, Katarzyna Bachanek‐Bankowska, Antiviral Research	2014	156
Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches Miriam Casey-Bryars, Richard Reeve, Umesh Bastola, Nature Ecology & Evolution VaccinationGlobal HealthInternational HealthDisease EmergenceDisease Outbreak	2018	101
A universal protocol to generate consensus level genome sequences for foot-and-mouth disease virus and other positive-sense polyadenylated RNA viruses using the Illumina MiSeq G. Logan, Graham Freimanis, David J. King, BMC Genomics	2014	84
Reconstructing the evolutionary history of pandemic foot-and-mouth disease viruses: the impact of recombination within the emerging O/ME-SA/Ind-2001 lineage Katarzyna Bachanek‐Bankowska, Antonello Di Nardo, Jemma Wadsworth, Scientific Reports	2018	83
Transplacental Transmission of Bluetongue Virus 8 in Cattle, UK Karin E. Darpel, Carrie Batten, Eva Veronesi, Emerging infectious diseases Transplacental TransmissionAnimal ScienceZoonotic DiseasePathogenesisEmergent Virus	2009	67
A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model Javier Castillo‐Olivares, Eva Calvo-Pinilla, Isabel Casanova, PLoS ONE VaccinationVeterinary VaccineVaccine DevelopmentAfrican Horse SicknessAhsv Infection	2011	64
Performance of Real-Time Reverse Transcription Polymerase Chain Reaction for the Detection of <i>Foot-and-Mouth Disease Virus</i> during Field Outbreaks in the United Kingdom in 2007 Scott M. Reid, Katja Ebert, Katarzyna Bachanek‐Bankowska, Journal of Veterinary Diagnostic Investigation	2009	53
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge Berta Alberca, Katarzyna Bachanek‐Bankowska, Marta Cabana, Vaccine	2014	52
Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2 Tamara Jabbar, Eva Calvo-Pinilla, Francisco Mateos, PLoS ONE Viral PathogenesisImmunologyImmune SystemImmunotherapyVaccine Target	2013	50

Page 1